(firstQuint)Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers.

 Healthy subjects will be enrolled and will receive doses of a test inhalation product and a reference inhalation product for 28 days according to a crossover design.

 Plasma tiotropium levels will be measured predose and over 24 hours postdose on days 1 and 28.

.

 Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers@highlight

The purpose of this study is to compare the absorption of a test inhalation product with the reference product in healthy volunteers.

